HuagongsheHuagongshe Chemistry Print Report · For research reference only
glucagon receptor antagonists-4 → HCID 68156267, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | glucagon receptor antagonists-4 | HCID 60151939 | — |
| Reactant | HCID 60152081 | HCID 60152081 | — |
| Reactant | HCID 60152478 | HCID 60152478 | — |
| Reactant | HCID 68156772 | HCID 68156772 | — |
| Reactant | HCID 68157647 | HCID 68157647 | — |
| Product | HCID 68156267 | HCID 68156267 | — |
Reaction Steps
(S)-3-(4-(1-(3,5-dimethyl-4-(4-(trifluoromethyl)-1H-pyrazol-1-yl)phenoxy)butyl)benzamido)propanoic acid; (R)-3-(4-(1-(3,5-dimethyl-4-(4-(trifluoromethyl)-1H-pyrazol-1-yl)phenoxy)butyl)benzamido)propanoic acid; (+/−)-3-(4-(cyclopentyl(6-(4-(trifluoromethyl)-1H-imidazol-1-yl)pyridin-3-ylamino)methyl)benzamido)propanoic acid; (R)-3-(4-(cyclopentyl(6-(4-(trifluoromethyl)-1H-imidazol-1-yl)pyridin-3-ylamino)methyl)benzamido)propanoic acid; and (S)-3-(4-(cyclopentyl(6-(4-(trifluoromethyl)-1H-imidazol-1-yl)pyridin-3-ylamino)methyl)benzamido)propanoic acid; or a pharmaceutically acceptable salt thereof.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08859591B2 |
| Source dataset | uspto-grants-2014_10 |
| ORD ID | ord-c232f7613629424b8ee254eaa8eaa472 |
| Source note | uspto-grants-2014_10 |